Company / R&D per Share
Upstream Bio, Inc. R&D per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.55
FY2025
5-year range
$2.55 / $10.77
FY2023-FY2025
Trend
-76.0%
vs FY2024
Sector context
#82 of 208
Health Care
What the data says
At $2.55, Upstream Bio, Inc.'s r&d per share ranks #82 of 208 in the Health Care sector. Declined from $10.77 to $2.55 over the past 2 years.
Based on SEC 10-K filings.
2.55 in FY2025.
Declined from $10.77 to $2.55 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#82 of 208 in Health CareTop 39% of 208This company $2.55 Sector average $28.82
▼
-91.1% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 76.0% year-over-year.
- Ranks #82 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.55 | -76.0% |
| FY2024 | $10.63 | -1.3% |
| FY2023 | $10.77 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026